Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

AH-001 could be a safer and more effective treatment for hair loss.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

A new compound that could treat various androgen-related conditions was created and analyzed.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.